Loading…

Safety and Efficacy of Nonanimal Stabilized Hyaluronic Acid for Improvement of Mouth Corners

BACKGROUNDEsthetic concern with downturned mouth corners (“mouth frown”) is increasing in the aging baby-boomer generation. A new technique to offer structural support using the recently approved filler nonanimal stabilized hyaluronic acid (NASHA; Restylane, Q-med Inc., Uppsala, Sweden) is described...

Full description

Saved in:
Bibliographic Details
Published in:Dermatologic surgery 2005-03, Vol.31 (3), p.276-280
Main Authors: Carruthers, Jean, Klein, Arnold W, Carruthers, Alastair, Glogau, Richard G, Canfield, Douglas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUNDEsthetic concern with downturned mouth corners (“mouth frown”) is increasing in the aging baby-boomer generation. A new technique to offer structural support using the recently approved filler nonanimal stabilized hyaluronic acid (NASHA; Restylane, Q-med Inc., Uppsala, Sweden) is described. METHODFifteen women with prominent downturned mouth corners met the inclusion criteria for the study. All were photographed before and at 1 week, 3 months, 4.5 months, and 6 months after treatment using a standardized clinical photographic system. NASHA was injected using a standardized technique with nerve block anesthesia to ensure patient comfort. RESULTSAll 15 women noted swelling, redness, and some local discomfort for several days after the injection. All noted an improvement in the downward angulation of their mouth corners at the first post-treatment visit, with at least partial improvement maintained through the 6-month post-treatment follow-up visit. CONCLUSIONSNASHA injection to support the age-related downturn of lateral lip corners was effective, safe, and well tolerated in a small prospective study of middle-aged female subjects. Esthetic satisfaction was greatest in the first 3 months post-treatment, but 40% of subjects still noted improvement at the 6-month follow-up visit.
ISSN:1076-0512
1524-4725
DOI:10.1097/00042728-200503000-00004